The Role of Amino Acid Sequence in the Self-Association of Therapeutic Monoclonal Antibodies: Insights from Coarse-Grained Modeling
- 25 January 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 117 (5) , 1269-1279
Abstract
Coarse-grained computational models of therapeutic monoclonal antibodies and their mutants can be used to understand the effect of domain-level charge–charge electrostatics on the self-association phenomena at high protein concentrations. The coarse-grained models are constructed for two antibodies at different coarse-grained resolutions by using six different concentrations. It is observed that a particular monoclonal antibody (hereafter referred to as MAb1) forms three-dimensional heterogeneous structures with dense regions or clusters compared to a different monoclonal antibody (hereafter referred to as MAb2) that forms homogeneous structures without clusters. The potential of mean force (PMF) and radial distribution functions (RDF) plots for the mutants (hereafter referred to as M1, M5, M7, and M10) show trends consistent with previously reported experimental observation of viscosities. The mutant referred to as M6 shows strongly attractive interactions that are consistent with previously reported negative second virial coefficients (B22) obtained from light-scattering experiments (Yadav et al. Pharm. Res.2011, 28, 1750–1764; Yadav et al. Mol. Pharmaceutics.2012, 9, 791–802). Clustering data on MAb1 reveal a small number of large clusters that are hypothesized to be the reason for the high experimental viscosity. This is in contrast with M6 (that differs from MAb1 in only a few amino acids), where cluster analysis reveals the formation of a large number of smaller clusters that is hypothesized to be the reason for the observed lower viscosity. The coarse-grained representations are effective in picking up differences based on local charge distributions of domains to make predictions on the self-association characteristics of these protein solutions.Keywords
This publication has 42 references indexed in Scilit:
- Therapeutic antibodies for autoimmunity and inflammationNature Reviews Immunology, 2010
- Formulation and manufacturability of biologicsCurrent Opinion in Biotechnology, 2009
- What's fueling the biotech engine—2008Nature Biotechnology, 2009
- Concluding summary: Proceedings of the AAPS Biotec Open Forum on “Aggregation of Protein Therapeutics”The AAPS Journal, 2006
- Protein aggregation and bioprocessingThe AAPS Journal, 2006
- Effects of protein aggregates: An immunologic perspectiveThe AAPS Journal, 2006
- Formulation and delivery issues for monoclonal antibody therapeuticsAdvanced Drug Delivery Reviews, 2006
- Protein drug stability: a formulation challengeNature Reviews Drug Discovery, 2005
- Challenges in the development of high protein concentration formulationsJournal of Pharmaceutical Sciences, 2004
- Immunotherapy: past, present and futureNature Medicine, 2003